Showing results (21-30 of 8,254) with videos related to
Sort By:
Pageof 826
Journal of Computer-Aided Molecular Design|July 1, 1988
Computer simulation of the binding of quinocarcin to DNA. Prediction of mode of action and absolute configurationG C Hill, T P Wunz, W A RemersJournal of Medicinal Chemistry|March 1, 1989
Preparation and antitumor activity of additional mitomycin A analoguesS M Sami, W A Remers, W T BradnerJournal of Medicinal Chemistry|October 1, 1981
Synthesis and antineoplastic activity of mitosene analogues of the mitomycinsJ C Hodges, W A Remers, W T BradnerJournal of Medicinal Chemistry|July 1, 1985
Synthesis and biological activity of 6-substituted mitosene analogues of the mitomycinsM L Casner, W A Remers, W T BradnerJournal of Medicinal Chemistry|January 1, 1986
Metal complexes of mitomycinsB S Iyengar, T Takahashi, W A Remers, et al.Journal of Medicinal Chemistry|January 1, 1977
Mitomycin antibiotics. Synthesis and activity of 1,2-disubstituted mitosenesW G Taylor, G Leadbetter, D L Fost, et al.Biochemistry|May 7, 1991
Steady-state fluorescence and molecular-modeling studies of tomaymycin-DNA adductsM D Barkley, T J Thomas, K Maskos, et al.Journal of Medicinal Chemistry|March 19, 1993
2-substituted 1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. A new class of antitumor agentS M Sami, R T Dorr, D S Alberts, et al.Journal of Medicinal Chemistry|August 1, 1988
Nucleotide derivatives of 2,7-diaminomitoseneB S Iyengar, R T Dorr, W A Remers, et al.Anti-Cancer Drugs|April 22, 1999
Intracellular localization of 6- and 7-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h]isoquino line-1,3-diones (azonafides) is not the limiting factor for their cytotoxicity: an in vitro confocal microscopy studyC A Mayr, S M Sami, W A Remers, et al.Pageof 826